Brief: RA Capital Management Reports 6.7% Passive Stake In 4D Molecular Therapeutics
05/06/2023 22:38
June 5 (Reuters) - 4D Molecular Therapeutics Inc
FDMT.O :
* RA CAPITAL MANAGEMENT, L.P. REPORTS 6.7% PASSIVE STAKE IN
4D
MOLECULAR THERAPEUTICS, INC. AS OF MAY 25, 2023 - SEC FILING
Further company coverage: FDMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings